A fresh era of earnings growth may be on the horizon.

The biotech has been on a tear lately.

Moderna (MRNA) drew fresh attention after appointing experienced financial executive Michael McDonnell to its Board and Audit ...

CAMBRIDGE, MA / ACCESS Newswire / July 16, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced the dosing of the first ...

Former Biogen Chief Financial Officer brings more than 35 years of financial leadership and public company experience CAMBRIDGE, MA / ACCESS Newswire / July 8, 2026 / Moderna, Inc. (NASDAQ:MRNA) today ...

French pharmaceutical company Sanofi has filed lawsuits against Pfizer and Moderna, claiming the companies used patented ...

Moderna's growth story is just beginning.

Now, it’s worth noting Stock Advisor’s total average return is 892 % — a market-crushing outperformance compared to 206% for the S&P 500. Don't miss the latest top 10 list, available with Stock ...

CNBC's Jim Cramer talks about his take on Moderna's stock performance and business outlook.

Moderna has countered a patent-infringement lawsuit brought by biotech company CureVac in Delaware federal court over its ...

Alex Hogan is STAT’s senior multimedia producer and host of STATus Report, STAT’s weekly video series. You can follow him on Bluesky. The story of the biotech company Moderna almost reads like a ...